RxDoctor Payments Data

Tsion Haileselassie

Pediatrics · Denton, TXNPI 1336366343

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Novo Nordisk at 48.6% of the total. Reporting peaked in 2020 at $286 and has fallen 70.3% since, to $85 in 2025.

$987in general payments, 2019–2025

Across 73 payments — averaging $13.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$480
  • Ironshore Pharmaceuticals Inc.$91
  • Amgen$64
  • Boehringer Ingelheim$48
  • Sun Pharmaceutical Industries Inc.$35
  • Genentech USA, Inc.$26
  • plus $243 from 15 others

What the payments were for

  • Food & beverage$987100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$987 in reported general payments places this provider in the 80th percentile of 5,361 pediatrics providers in Texas.

See all pediatrics providers in Texas →

Other pediatrics in Denton

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →